Dch Burn Relief

Description

The product is a topical gel formulation identified by SPL Code 34089-3. It contains Lidocaine as the active ingredient, which is intended for the relief of pain and discomfort. The gel is composed of several inactive ingredients, including Carbomer, Glycerin, Propylene Glycol, Purified Water, Sodium Hydroxide, and Triethanolamine. It is characterized by its clear and colorless appearance.

Uses and Indications

This drug is indicated for the topical treatment of affected areas in adults and children aged 2 years and older. It should be applied no more than 3 to 4 times a day. For children under 2 years of age, consultation with a physician is recommended prior to use.

When applying to the face, the drug should be squeezed into the palm of the hand and gently applied to the affected area.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For the temporary relief of pain and itching associated with sunburn, minor burns, insect bites, minor cuts, scrapes, and minor skin irritations, the recommended dosage is to apply the product directly to the affected area. The application should be performed as needed, ensuring that the area is clean and dry prior to use.

Healthcare professionals should advise patients to use the product no more than three to four times daily, depending on the severity of symptoms. It is important to monitor the treated area for any signs of adverse reactions or worsening of the condition. If symptoms persist or worsen, patients should be instructed to seek further medical advice.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, immediate medical assistance should be sought, or contact a Poison Control Center without delay.

Warnings and Precautions

For external use only. It is imperative that this product is not applied in large quantities, especially on raw surfaces or blistered areas, to prevent adverse effects.

Care should be taken to avoid contact with the eyes during application. In the event of accidental contact, it is essential to rinse the eyes thoroughly with water to mitigate any potential irritation.

Healthcare professionals should advise patients to discontinue use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

This product must be kept out of reach of children. In cases where the product is ingested, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended to ensure appropriate management.

Side Effects

Patients should be aware that this product is intended for external use only. It is important to avoid using large quantities, especially over raw surfaces or blistered areas, as this may lead to adverse effects.

During the use of this product, contact with the eyes should be strictly avoided. In the event of accidental contact, it is recommended to rinse the eyes thoroughly with water.

Patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Dch Burn Relief (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 years and older may apply the medication to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of this product during pregnancy has not been established. Use of this product is contraindicated in pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a physician before use to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. It is important to emphasize that if the product is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This information is crucial for ensuring the safety and well-being of patients and their families.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application frequency of 3 to 4 times daily for adults and children aged 2 years and older. For children under 2 years, consultation with a physician is advised. When applying to the face, it should be squeezed into the palm and gently applied.

Clinicians should counsel patients to avoid using the product in large quantities, especially on raw surfaces or blistered areas. Patients are also advised to avoid contact with the eyes, rinsing with water if contact occurs. They should discontinue use and consult a doctor if the condition worsens, symptoms persist beyond 7 days, or if symptoms resolve and then recur shortly thereafter. Additionally, the product should be kept out of reach of children, and immediate medical assistance should be sought if ingested.

Drug Information (PDF)

This file contains official product information for Dch Burn Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)